This brand name is authorized in France, Tunisia
The drug RHINOFLUIMUCIL contains a combination of these active pharmaceutical ingredients (APIs):
1
Acetylcysteine
UNII WYQ7N0BPYC - ACETYLCYSTEINE
|
Acetylcysteine is N-acetyl derivative of cysteine. Used as a mucolytic agent to reduce the viscosity of mucous secretions. |
2
Benzalkonium chloride
UNII F5UM2KM3W7 - BENZALKONIUM CHLORIDE
|
|
3
Tuaminoheptane
UNII WZK5LN5CNW - TUAMINOHEPTANE SULFATE
|
|
This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:
ATC code | Group title | Classification |
---|---|---|
R01AB08 | Tuaminoheptane | R Respiratory system → R01 Nasal preparations → R01A Decongestants and other nasal preparations for topical use → R01AB Sympathomimetics, combinations excl. corticosteroids |
This drug has been assigned below unique identifiers within the countries it is being marketed:
Country | Identification scheme | Identifier(s) |
---|---|---|
Country: FR | Base de donnรฉes publique des mรฉdicaments | Identifier(s): 62249357 |
Country: TN | Direction de la Pharmacie et du Mรฉdicament | Identifier(s): 2983021 |
ยฉ All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.